Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
- PMID: 31153829
- DOI: 10.1016/j.jmii.2019.04.011
Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
Abstract
The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae.
Keywords: Extra-pulmonary diseases; Immune-mediated diseases; Mycoplasma pneumoniae.
Copyright © 2019. Published by Elsevier B.V.
Comment in
-
Reply to correspondence of Dr. Dimitri Poddighe.J Microbiol Immunol Infect. 2020 Feb;53(1):190. doi: 10.1016/j.jmii.2019.05.002. Epub 2019 May 21. J Microbiol Immunol Infect. 2020. PMID: 31151768 No abstract available.
Comment on
-
Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?J Microbiol Immunol Infect. 2019 Apr;52(2):329-335. doi: 10.1016/j.jmii.2018.09.009. Epub 2018 Oct 9. J Microbiol Immunol Infect. 2019. PMID: 30341022
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
